Central Serous Chorioretinopathy - 26 Studies Found

Completed : High-dose Antioxidants for Central Serous Chorioretinopathy
: Central Serous Chorioretinopathy
: 2009-08-20
: Drug: antioxidants tablets vitamin A 6600 IU, vitamin C 400 mg, vitamin E 150 IU, riboflavin 10 mg, zinc
Completed : Methotrexate for Central Serous Chorioretinopathy Treatment Trial
: Central Serous Chorioretinopathy
: 2012-07-02
:
  • Drug: Methotrexate 7.5 mg per

Completed : Short-Term Oral Mifepristone for Central Serous Chorioretinopathy
: Central Serous Chorioretinopathy
: 2015-01-29
:
  • Drug: Mifepristone
  • Drug: Placebo
Completed : Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate
: Chronic Central Serous Chorioretinopathy
: 2007-06-20
:
  • Drug: Anecortave Acetate Sterile suspension 15 mg

Completed : Eplerenone for Central Serous Chorioretinopathy
: Central Serous Chorioretinopathy
: 2013-03-25
: Drug: Eplerenone 50mg All patients will receive the same dose of eplerenone.
Completed : The Safe Effective Light Dose of Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
: Central Serous Chorioretinopathy
: 2012-06-26
: Procedure: Photodynamic therapy Photodynamic therapy is performed using verteporfin. Full dose of vertep
Completed : Comparison of Multifocal Electroretinogram Assessment in Chronic Central Serous Chorioretinopathy (CSC) Between Laser Treatment Group and Photodynamic Therapy Group in Chronic Central Serous Chorioretinopathy
: Central Serous Chorioretinopathy
: 2008-11-12
Not yet recruiting : A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy
: Central Serous Chorioretinopathy
: 2014-08-11
:
  • Drug: Eplerenone
  • Drug: Maltodextrin
Completed : Eplerenone for the Treatment of Central Serous Chorioretinopathy
: Central Serous Chorioretinopathy
: 2013-11-15
:
  • Drug: 25mg Eplerenone Patients
Completed : Central Serous Chorioretinopathy Treated by Modified Photodynamic Therapy
: Central Serous Chorioretinopathy
: 2009-11-19
:
  • Drug: Verteporfin PDT, half-dose

Next >>>